Manager, FP&A

Non-small Cell Lung Cancer (NSCLC)

• HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI.
• HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC.
• HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC.

Colorectal Cancer (CRC)

• HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy.

Ivonescimab is an investigational therapy not presently approved by any regulatory authority other than China's National Medical Products Administration (NMPA). Summit is headquartered in Miami, Florida, and has additional offices in California, New Jersey, the UK, and Ireland.

Overview of Role

Reporting to the Associate Director, FP&A, this position partners closely with functional leaders and FP&A/Accounting teams to deliver monthly financial reporting, compare actual results against forecast and budget, support budgeting and strategic/financial planning, and drive improvements in reporting processes and data transparency. It is a high-impact role for a detail-oriented analyst who will provide the insights needed for executive decision-making.

Role and Responsibilities

• Assist in the preparation of the annual operating plan, quarterly forecasts, and long-range models for CMC, Supply Chain, and Medical Affairs
• Provide planning, reporting, and analysis of COGS, identifying drivers, risks, and opportunities
• Perform detailed financial analysis, provide insights, and prepare monthly reporting packages for functional teams to track spending against budget
• Partner with supply chain, procurement, and operations to evaluate cost drivers and identify savings opportunities
• Manage and review the purchasing plan forecast to align with the clinical supply chain during monthly S&OP
• Review and evaluate contracts for financial implications, cost structures, and risk exposure
• Partner with the Accounting team during month-end close to review accruals and track activities across various projects and cost centers
• Proactively identify opportunities to streamline financial processes and enhance standard product cost analysis
• Assist with ad hoc projects as needed
• All other duties as assigned

Experience, Education and Specialized Knowledge and Skills

• Minimum bachelor's degree in Finance, Accounting and Business Administration
• Minimum 5+ years of experience in budgeting and financial
• Results-oriented, strong organizational skills, and time management skills with ability to multi-task
• Strong analytical, problem-solving and financial modeling skills
• Advanced Excel skills
• Demonstrated ability to operate in a fast-paced environment
• Attention to detail, accuracy and confidentiality
• An ability to work well cross functionally and across geographies

This is the pay for this position

Pay Transparency $139,000—$163,000 USD

Actual compensation packages are based on several factors that are unique to each candidate, including but not limited to skill set, depth of experience, certifications, and specific work location. This may be different in other locations due to differences in the cost of labor. The total compensation package for this position may also include bonus, stock, benefits and/or other applicable variable compensation.

Summit does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact Summit's Talent Acquisition team at to obtain prior written authorization before referring any candidates to Summit.